A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinoma.
暂无分享,去创建一个
X. Yao | B. Dai | Yi-jun Shen | D. Ye | G. Lin | Hai-Liang Zhang | Yao Zhu | G. Shi | Chun-guang Ma | Shi-lin Zhang | X. Qin | Hong-kai Wang | Yi-Ping Zhu | W. Xiao | Chun-guang Ma | Yijun Shen